Last reviewed · How we verify
Prasugrel or Clopidogrel
Prasugrel or Clopidogrel is a Small molecule drug developed by University of Patras. It is currently FDA-approved.
At a glance
| Generic name | Prasugrel or Clopidogrel |
|---|---|
| Sponsor | University of Patras |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI (PHASE4)
- The Switching Antiplatelet-9 (SWAP-9) Study (PHASE4)
- Bariatric Surgery for the Reduction of cArdioVascular Events Randomized Controlled Trial (NA)
- ARCANGELO (itAlian pRospective Study on CANGrELOr)
- Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion (PHASE4)
- STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT (NA)
- VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (PHASE4)
- Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Prasugrel or Clopidogrel CI brief — competitive landscape report
- Prasugrel or Clopidogrel updates RSS · CI watch RSS
- University of Patras portfolio CI
Frequently asked questions about Prasugrel or Clopidogrel
What is Prasugrel or Clopidogrel?
Prasugrel or Clopidogrel is a Small molecule drug developed by University of Patras.
Who makes Prasugrel or Clopidogrel?
Prasugrel or Clopidogrel is developed and marketed by University of Patras (see full University of Patras pipeline at /company/university-of-patras).
What development phase is Prasugrel or Clopidogrel in?
Prasugrel or Clopidogrel is FDA-approved (marketed).
Related
- Manufacturer: University of Patras — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing